How to Address the IP Issues Specifically Associated with Polymorphic Forms

Hosted By: Pharma IQ
09/28/2010
Rate this Podcast: 
Be the first!
To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.
Join

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

About this Podcast...

It is becoming increasingly important to have a successful application and litigation strategy to protect and maximise the revenue from existing patents. A substantial proportion of pharmaceutical products are crystalline forms which, due to the intricacies of obviousness and novelty, are notoriously difficult to patent and litigate. In this podcast Dr. Alpesh Pathak, Head - Patent Cell at Alembic Research Center, shares his insights with Andrea Charles from Pharma IQ, regarding the IP landscape for pharmaceutical crystalline and polymorphic forms. Pathak also discusses the unique challenges surrounding patenting pharmaceutical crystalline and polymorphic forms and how the industry is responding to these issues.

EVENTS OF INTEREST

Crowne Plaza Zurich, Zurich, Switzerland
June 17 - 19, 2018